SANTIAGO, Chile, March 2 — As a journalist, Augusto Gongora fought to chronicle Chile’s violent military dictatorship. But it was his battle to hold onto his own memories that made him the subject of an Oscar-nominated documentary. The Eternal Memory charts the progression of Alzheimer’s disease through the lens of a couple who had to … Read more
ZURICH, Switzerland, Jan. 31, 2024 (GLOBE NEWSWIRE) — Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid. Aducanumab was granted FDA accelerated approval for the treatment of Alzheimer’s disease. Neurimmune licensed its antibody aducanumab for the treatment and prevention of Alzheimer’s disease to Biogen in … Read more
Research demonstrated that activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer’s Disease (AD). ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome ASC specks to block initiation and perpetuation of damaging inflammation in the central nervous system and peripheral tissues. WESTON, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) … Read more
SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) — Hagens Berman urges BioVie Inc. (NASDAQ: BIVI) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/BIVI Contact An Attorney Now: BIVI@hbsslaw.com 844-916-0895 … Read more
